Works by Fox, Christopher P

Results: 55
    1
    2
    3

    Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum.

    Published in:
    Rheumatology, 2022, v. 61, n. 7, p. 2783, doi. 10.1093/rheumatology/keab790
    By:
    • Nakafero, Georgina;
    • Grainge, Matthew J;
    • Card, Tim;
    • Taal, Maarten W;
    • Aithal, Guruprasad P;
    • Zhang, Weiya;
    • Doherty, Michael;
    • Fox, Christopher P;
    • Mallen, Christian D;
    • Abhishek, Abhishek
    Publication type:
    Article
    4

    Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort.

    Published in:
    Advances in Therapy, 2021, v. 38, n. 7, p. 3789, doi. 10.1007/s12325-021-01764-0
    By:
    • Martinez-Calle, Nicolas;
    • Kirkwood, Amy A.;
    • Lamb, Maxine;
    • Smith, Alex;
    • Khwaja, Jahanzaib;
    • Manos, Kate;
    • Shrubsole, Caroline;
    • Gray, Nicola;
    • Lewis, Katharine;
    • Tivey, Ann;
    • Bishton, Mark J.;
    • Hawkes, Eliza;
    • Ahearne, Matthew J.;
    • Osborne, Wendy;
    • Collins, Graham P.;
    • Illidge, Timothy;
    • Linton, Kim M.;
    • Cwynarski, Kate;
    • Burton, Cathy;
    • Fox, Christopher P.
    Publication type:
    Article
    5
    6

    Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up.

    Published in:
    HemaSphere, 2024, v. 8, n. 6, p. 1, doi. 10.1002/hem3.89
    By:
    • Ferreri, Andreas J. M.;
    • Illerhaus, Gerald;
    • Doorduijn, Jeanette K.;
    • Auer, Dorothee P.;
    • Bromberg, Jacoline E. C.;
    • Calimeri, Teresa;
    • Cwynarski, Kate;
    • Fox, Christopher P.;
    • Hoang‐Xuan, Khê;
    • Malaise, Denis;
    • Ponzoni, Maurilio;
    • Schorb, Elisabeth;
    • Soussain, Carole;
    • Specht, Lena;
    • Zucca, Emanuele;
    • Buske, Christian;
    • Jerkeman, Mats;
    • Dreyling, Martin
    Publication type:
    Article
    7

    P648: REAL‐WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST‐LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969496.68553.26
    By:
    • Lansigan, Frederick;
    • A. Eyre, Toby;
    • Ghosh, Nilanjan;
    • S. Manzoor, Beenish;
    • C. Coombs, Catherine;
    • Lamanna, Nicole;
    • H. Tuncer, Hande;
    • Emechebe, Dozie;
    • R. Brown, Jennifer;
    • E. Roeker, Lindsey;
    • Ujjani, Chaitra;
    • Alhasani, Hasan;
    • Fleury, Isabelle;
    • A. Leslie, Lori;
    • Skarbnik, Alan;
    • Rhodes, Joanna;
    • T. Hill, Brian;
    • M. Barr, Paul;
    • S. Davids, Matthew;
    • P. Fox, Christopher
    Publication type:
    Article
    8

    Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum.

    Published in:
    Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac046
    By:
    • Nakafero, Georgina;
    • Grainge, Matthew J;
    • Card, Tim;
    • Mallen, Christian D;
    • Riley, Richard;
    • van der Windt, Danielle;
    • Fox, Christopher P;
    • Taal, Maarten W;
    • Aithal, Guruprasad P;
    • Williams, Hywel C;
    • Abhishek, Abhishek
    Publication type:
    Article
    9
    10
    11

    Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 3, p. 573, doi. 10.1080/10428194.2022.2160200
    By:
    • Van Le, Hoa;
    • Van Naarden Braun, Kim;
    • Nowakowski, Grzegorz S.;
    • Sermer, David;
    • Radford, John;
    • Townsend, William;
    • Ghesquieres, Herve;
    • Menne, Tobias;
    • Porpaczy, Edit;
    • Fox, Christopher P.;
    • Schusterbauer, Claudia;
    • Liu, Fei Fei;
    • Yue, Lihua;
    • De Benedetti, Marc;
    • Hasskarl, Jens
    Publication type:
    Article
    12

    A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 11, p. 2625, doi. 10.1080/10428194.2021.1938027
    By:
    • Collins, Graham P.;
    • Clevenger, Tracy N.;
    • Burke, Kathleen A.;
    • Yang, Buyue;
    • MacDonald, Alex;
    • Cunningham, David;
    • Fox, Christopher P.;
    • Goy, Andre;
    • Gribben, John;
    • Nowakowski, Grzegorz S.;
    • Roschewski, Mark;
    • Vose, Julie M.;
    • Vallurupalli, Anusha;
    • Cheung, Jean;
    • Raymond, Amelia;
    • Nuttall, Barrett;
    • Stetson, Dan;
    • Dougherty, Brian A.;
    • Schalkwijk, Stein;
    • Carnevalli, Larissa S.
    Publication type:
    Article
    13
    14
    15
    16

    High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 12, p. 3295, doi. 10.3109/10428194.2015.1037764
    By:
    • Fox, Christopher P.;
    • Boumendil, Ariane;
    • Schmitz, Norbert;
    • Finel, Herve;
    • Luan, Jian J.;
    • Sucak, Gülsan;
    • Blaise, Didier;
    • Finke, Jürgen;
    • Pflüger, Karl-Heinz;
    • Veelken, Hendrik;
    • Gorin, Norbert -Claude;
    • Poiré, Xavier;
    • Ganser, Arnold;
    • Dreger, Peter;
    • Sureda, Anna
    Publication type:
    Article
    17
    18
    19

    Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 7, p. 1056, doi. 10.1093/neuonc/noab020
    By:
    • Barajas, Ramon F;
    • Politi, Letterio S;
    • Anzalone, Nicoletta;
    • Schöder, Heiko;
    • Fox, Christopher P;
    • Boxerman, Jerrold L;
    • Kaufmann, Timothy J;
    • Quarles, C Chad;
    • Ellingson, Benjamin M;
    • Auer, Dorothee;
    • Andronesi, Ovidiu C;
    • Ferreri, Andres J M;
    • Mrugala, Maciej M;
    • Grommes, Christian;
    • Neuwelt, Edward A;
    • Ambady, Prakash;
    • Rubenstein, James L;
    • Illerhaus, Gerald;
    • Nagane, Motoo;
    • Batchelor, Tracy T
    Publication type:
    Article
    20
    21
    22
    23
    24

    Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel.

    Published in:
    Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00268-z
    By:
    • Cartron, Guillaume;
    • Fox, Christopher P.;
    • Liu, Fei Fei;
    • Kostic, Ana;
    • Hasskarl, Jens;
    • Li, Daniel;
    • Bonner, Ashley;
    • Zhang, Yixie;
    • Maloney, David G.;
    • Kuruvilla, John
    Publication type:
    Article
    25

    Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies.

    Published in:
    British Journal of Dermatology, 2024, v. 190, n. 4, p. 559, doi. 10.1093/bjd/ljad430
    By:
    • Abhishek, Abhishek;
    • Stevenson, Matthew D;
    • Nakafero, Georgina;
    • Grainge, Matthew J;
    • Evans, Ian;
    • Alabas, Oras;
    • Card, Tim;
    • Taal, Maarten W;
    • Aithal, Guruprasad P;
    • Fox, Christopher P;
    • Mallen, Christian D;
    • Windt, Danielle A van der;
    • Riley, Richard D;
    • Warren, Richard B;
    • Williams, Hywel C
    Publication type:
    Article
    26
    27
    28
    29

    Venetoclax ramp‐up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.

    Published in:
    British Journal of Haematology, 2023, v. 202, n. 1, p. 48, doi. 10.1111/bjh.18738
    By:
    • Figueroa‐Mora, Rocio;
    • Rampotas, Alexandros;
    • Halperin, Daniel;
    • Worth, Tina;
    • Vidler, Jennifer;
    • Melotti, Dario;
    • Ferguson, Paul;
    • Elmusharaf, Nagah;
    • Preston, Gavin;
    • Furtado, Michelle;
    • Dungarwalla, Moez;
    • Gohill, Satyen;
    • Patten, Piers;
    • Kennedy, Ben;
    • Eyre, Toby A.;
    • Schuh, Anna;
    • Fox, Christopher P.;
    • Munir, Tahla;
    • Martinez‐Calle, Nicolas
    Publication type:
    Article
    30

    Management of secondary central nervous system lymphoma.

    Published in:
    British Journal of Haematology, 2023, v. 200, n. 2, p. 160, doi. 10.1111/bjh.18539
    By:
    • Cwynarski, Kate;
    • Cummin, Thomas;
    • Osborne, Wendy;
    • Lewis, Joanne;
    • Chaganti, Sridhar;
    • Smith, Jeff;
    • Linton, Kim;
    • Greaves, Paul;
    • McKay, Pam;
    • Fox, Christopher P.
    Publication type:
    Article
    31

    Impact of severe acute respiratory syndrome coronavirus‐2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 4, p. 507, doi. 10.1111/bjh.18396
    By:
    • Steffanoni, Sara;
    • Calimeri, Teresa;
    • Laurenge, Alice;
    • Fox, Christopher P.;
    • Soussain, Carole;
    • Grommes, Christian;
    • Tisi, Maria Chiara;
    • Boot, Jesca;
    • Crosbie, Nicola;
    • Visco, Carlo;
    • Arcaini, Luca;
    • Chaganti, Sridhar;
    • Sassone, Marianna C.;
    • Alencar, Alvaro;
    • Armiento, Daniele;
    • Romano, Ilaria;
    • Dietrich, Jorg;
    • Itchaki, Gilad;
    • Bruna, Riccardo;
    • Fracchiolla, Nicola S.
    Publication type:
    Article
    32
    33
    34

    Improved survival outcomes despite older age at diagnosis: an era‐by‐era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 4, p. 561, doi. 10.1111/bjh.17747
    By:
    • Kaji, Furqaan A.;
    • Martinez‐Calle, Nicolas;
    • Bishton, Mark J.;
    • Figueroa, Rocio;
    • Adlington, Joanne;
    • O'Donoghue, Michael;
    • Smith, Stuart;
    • Byrne, Paul;
    • Paine, Simon;
    • Sovani, Vishakha;
    • Auer, Dorothee;
    • James, Eleanor;
    • Bessell, Eric M.;
    • Grainge, Matthew J.;
    • Fox, Christopher P.
    Publication type:
    Article
    35

    Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients — A British Society for Haematology Guideline.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 4, p. 727, doi. 10.1111/bjh.17421
    By:
    • Shah, Nimish;
    • Eyre, Toby A.;
    • Tucker, David;
    • Kassam, Shireen;
    • Parmar, Jasvir;
    • Featherstone, Carrie;
    • Andrews, Peter;
    • Asgari, Elham;
    • Chaganti, Sridhar;
    • Menne, Tobias F.;
    • Fox, Christopher P.;
    • Pettit, Stephen;
    • Suddle, Abid;
    • Bowles, Kristian M.
    Publication type:
    Article
    36
    37

    Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice.

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 5, p. 879, doi. 10.1111/bjh.16451
    By:
    • Schorb, Elisabeth;
    • Fox, Christopher P.;
    • Kasenda, Benjamin;
    • Linton, Kim;
    • Martinez‐Calle, Nicolas;
    • Calimeri, Teresa;
    • Ninkovic, Slavisa;
    • Eyre, Toby A.;
    • Cummin, Tom;
    • Smith, Jeffery;
    • Yallop, Deborah;
    • De Marco, Beatrice;
    • Krampera, Mauro;
    • Trefz, Stefan;
    • Orsucci, Lorella;
    • Fabbri, Alberto;
    • Illerhaus, Gerald;
    • Cwynarski, Kate;
    • Ferreri, Andrés J. M.
    Publication type:
    Article
    38

    The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2020, v. 188, n. 6, p. 918, doi. 10.1111/bjh.16271
    By:
    • Eyre, Toby A.;
    • Roeker, Lindsey E.;
    • Fox, Christopher P.;
    • Gohill, Satyen H.;
    • Walewska, Renata;
    • Walter, Harriet S.;
    • Forconi, Francesco;
    • Broom, Angus;
    • Arumainathan, Arvind;
    • Brander, Danielle M.;
    • Allan, John N.;
    • Schuster, Stephen J.;
    • Hill, Brian T.;
    • Lansigan, Frederick;
    • Cheson, Bruce D.;
    • Lamanna, Nicole;
    • Coombs, Catherine C.;
    • Barr, Paul M.;
    • Skarbnik, Alan P.;
    • Shadman, Mazyar
    Publication type:
    Article
    39

    Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity.

    Published in:
    British Journal of Haematology, 2019, v. 187, n. 2, p. 185, doi. 10.1111/bjh.16070
    By:
    • Eyre, Toby A.;
    • Kirkwood, Amy A.;
    • Wolf, Julia;
    • Hildyard, Catherine;
    • Mercer, Carolyn;
    • Plaschkes, Hannah;
    • Griffith, John;
    • Fields, Paul;
    • Gunawan, Arief;
    • Oliver, Rebecca;
    • Booth, Stephen;
    • Martinez‐Calle, Nicolas;
    • McMillan, Andrew;
    • Bishton, Mark;
    • Fox, Christopher P.;
    • Collins, Graham P.;
    • Hatton, Chris S. R.
    Publication type:
    Article
    40

    Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP.

    Published in:
    British Journal of Haematology, 2019, v. 186, n. 4, p. e94, doi. 10.1111/bjh.15927
    By:
    • Eyre, Toby A.;
    • Martinez‐Calle, Nicolas;
    • Hildyard, Catherine;
    • Eyre, David W.;
    • Plaschkes, Hannah;
    • Griffith, John;
    • Wolf, Julia;
    • Fields, Paul A.;
    • Gunawan, Arief;
    • Oliver, Rebecca;
    • Booth, Stephen;
    • McMillan, Andrew;
    • Fox, Christopher P.;
    • Bishton, Mark;
    • Collins, Graham P.;
    • Hatton, Chris S. R.
    Publication type:
    Article
    41

    Kinetics of T‐cell subset reconstitution following treatment with bendamustine and rituximab for low‐grade lymphoproliferative disease: a population‐based analysis.

    Published in:
    British Journal of Haematology, 2019, v. 184, n. 6, p. 957, doi. 10.1111/bjh.15722
    By:
    • Martínez‐Calle, Nicolás;
    • Hartley, Sarah;
    • Ahearne, Matthew;
    • Kasenda, Benjamin;
    • Beech, Amy;
    • Knight, Helen;
    • Balotis, Constantine;
    • Kennedy, Ben;
    • Wagner, Simon;
    • Dyer, Martin J. S.;
    • Smith, Dean;
    • McMillan, Andrew K.;
    • Miall, Fiona;
    • Bishton, Mark;
    • Fox, Christopher P.
    Publication type:
    Article
    42
    43
    44

    Guideline for the treatment of chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 344, doi. 10.1111/bjh.15460
    By:
    • Schuh, Anna H.;
    • Parry‐Jones, Nilima;
    • Appleby, Niamh;
    • Bloor, Adrian;
    • Dearden, Claire E.;
    • Fegan, Christopher;
    • Follows, George;
    • Fox, Christopher P.;
    • Iyengar, Sunil;
    • Kennedy, Ben;
    • McCarthy, Helen;
    • Parry, Helen M.;
    • Patten, Piers;
    • Pettitt, Andrew R.;
    • Ringshausen, Ingo;
    • Walewska, Renata;
    • Hillmen, Peter
    Publication type:
    Article
    45
    46
    47
    48

    NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.

    Published in:
    British Journal of Haematology, 2016, v. 175, n. 1, p. 43, doi. 10.1111/bjh.14177
    By:
    • Eyre, Toby A.;
    • Clifford, Ruth;
    • Bloor, Adrian;
    • Boyle, Lucy;
    • Roberts, Corran;
    • Cabes, Maite;
    • Collins, Graham P.;
    • Devereux, Stephen;
    • Follows, George;
    • Fox, Christopher P.;
    • Gribben, John;
    • Hillmen, Peter;
    • Hatton, Chris S.;
    • Littlewood, Tim J.;
    • McCarthy, Helen;
    • Murray, Jim;
    • Pettitt, Andrew R.;
    • Soilleux, Elizabeth;
    • Stamatopoulos, Basile;
    • Love, Sharon B.
    Publication type:
    Article
    49

    Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis.

    Published in:
    British Journal of Haematology, 2016, v. 172, n. 2, p. 246, doi. 10.1111/bjh.13831
    By:
    • Bishton, Mark J.;
    • Hughes, Simon;
    • Richardson, Faith;
    • James, Eleanor;
    • Bessell, Eric;
    • Sovani, Vishakha;
    • Ganatra, Rakesh;
    • Haynes, Andrew P.;
    • McMillan, Andrew K.;
    • Fox, Christopher P.
    Publication type:
    Article
    50